Unclaimed brand
Learn about an FDA‑approved treatment for narcolepsy patients 7 and up with cataplexy or EDS and adults with Idiopathic Hypersomnia (IH). See full Prescribing Information & BOXED Warning about serious side effects, CNS depression, and misuse and abuse.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#F93549
Coral Red
249, 53, 73
354, 94, 59
0, 79, 71, 2
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#1E1C1A
Cod Gray
30, 28, 26
30, 7, 11
0, 7, 13, 88
XYWAV® is a trusted brand offering oral solutions of calcium, magnesium, potassium, and sodium oxybates. Specifically formulated for individuals with cataplexy, excessive daytime sleepiness (EDS) related to narcolepsy, or adults with idiopathic hypersomnia (IH). Only FDA-approved, XYWAV oral solution effectively treats cataplexy and EDS in narcolepsy, as well as IH in adults.
However, caution is advised when using XYWAV with other CNS depressants due to potential serious side effects like respiratory depression and hypotension. The active ingredient, gamma-hydroxybutyrate (GHB), necessitates adherence to strict safety guidelines to prevent misuse. XYWAV is integral in enhancing the quality of life for those with sleep disorders, emphasizing safety and efficacy.
Discover the benefits of XYWAV for managing symptoms and improving overall well-being. Trust XYWAV for narcolepsy and IH treatment, ensuring optimal care and safety. Prioritize your health with XYWAV
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
Mixed-salt oxybate oral solution
Narcolepsy medication
Cataplexy treatment
Idiopathic hypersomnia medication
